| 1 |
33572814 | HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma. | 2021 Jan 29 |
2 |
| 2 |
34837676 | AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines. | 2021 Oct |
1 |
| 3 |
32298237 | Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis. | 2020 Apr 16 |
1 |
| 4 |
31337650 | IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma. | 2019 Sep 15 |
3 |
| 5 |
31456939 | Carnosol, a Natural Polyphenol, Inhibits Migration, Metastasis, and Tumor Growth of Breast Cancer via a ROS-Dependent Proteasome Degradation of STAT3. | 2019 |
1 |
| 6 |
29899697 | Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade. | 2018 |
1 |
| 7 |
29914181 | Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model. | 2018 Jun 16 |
1 |
| 8 |
28000897 | Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma. | 2017 Feb |
8 |
| 9 |
24407159 | Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro. | 2014 Apr |
3 |
| 10 |
24627094 | Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2. | 2014 May |
2 |
| 11 |
24627483 | Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy. | 2014 May 2 |
3 |
| 12 |
24824872 | Bortezomib induces apoptosis by interacting with JAK/STAT pathway in K562 leukemic cells. | 2014 Aug |
1 |
| 13 |
23279849 | Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1. | 2013 Apr 1 |
1 |
| 14 |
19608275 | Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. | 2010 Jan |
1 |
| 15 |
20663948 | Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma. | 2010 Nov |
4 |
| 16 |
19331127 | Bortezomib therapeutic effect is associated with expression of FGFR3 in multiple myeloma cells. | 2009 Jan |
2 |
| 17 |
19638453 | Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death. | 2009 Aug |
13 |
| 18 |
18690088 | Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells. | 2008 Sep |
1 |
| 19 |
19383353 | Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. | 2008 Dec |
1 |
| 20 |
14627979 | Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma. | 2003 Nov 20 |
2 |